Search published articles


Showing 2 results for Vardasbi Joybary

Rezaei Sh, Salehipour M, Golestani A, Vardasbi Joybary I S, Nafisi Sh, Doosti M, Golmohammadi T,
Volume 69, Issue 3 (5 2011)
Abstract

Background: Thymidine phosphorylase (TP) catalyses the conversion of thymidine into thymine. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disease which is caused by mutations in the nuclear gene encoding TP, bringing about severe impairment of TP-enzyme specific activity and accumulation of thymidine in plasma. The clinical manifestations of MNGIE are recognizable and homogenous, but not in the early stages of the disease. In patients who are suspected of having MNGIE, determination of TP-specific activity in leukocytes and thymidine levels in plasma are diagnostic. The methods that are usually used for the measurement of TP activity and plasma thymidine are not rapid or accurate enough and lack sensitivity.

Methods: The specific activity of TP was measured by RP-HPLC in leukocytes of both the controls and the patients exhibiting clinical features suggestive of MNGIE. Moreover, plasma thymidine was assessed by the same method.

Results: The patients had detectable plasma thymidine (>3 µmol/L) but it was undetectable in the healthy controls. The patients' TP-specific activity decreased to less than 5% relative to the controls (14±4 nmol/h/mg vs. 525±165 nmol/h/mg, P<0.05). A diagnostic algorithm for the definitive diagnosis of MNGIE is suggestible based on the results of this study which relies on the measurement of plasma thymidine, TP-specific activity in leukocytes, or both.

Conclusion: In this study, we set up a sensitive and rapid assay for the evaluation of TP-specific activity by using RP-HPLC in Iran. In addition, we established reference values for TP-specific activity and plasma thymidine in the Iranian patients.


Iraj Ragerdi Kashani , Mohammad Ansari , Kobra Mehrannia , Kasra Moazzemi , Safura Vardasbi Joybary ,
Volume 71, Issue 8 (November 2013)
Abstract

Background: A number of studies on reproduction have mentioned Origanum Vulgare extract’s ability to reduce mortality rates and improve fertility rates. However, other studies have suggested that it is possible to use Origanum Vulgare extract to induce abortion. The aim of this study was to investigate the effect of different doses of Origanum Vulgare on embryo survival and macroscopic abnormalities in mice.
Methods: In this study, 24 mice Balb/c female weighting approximately 25-30 g were divided into 4 groups. Origanum Vulgare extract was prepared different concentrations (2.5, 12.5, and 25 mg in 0.25 ml distilled water) were administered, by oral gavage, to three experimental groups of mice between day 6 (starting gastrulation) until day 15 of pregnancy (end of organogenesis). The control group consisted of six mice that received 0.25 ml of distilled water daily. On day 16 of study, pregnant mice were anesthetized by chloroform and fetuses were removed and stained with Alcian Blue, Alizarin Red s and microwave irradiation. Morphological and skeletal abnormalities were investigated by light and stereomicroscopes.
Results: The results of this study showed that high doses of the Origanum Vulgare extract significantly decreased the mean number of embryos (100.5, P>0.05), mean number of live embryos (70.5, P>0.05) in each mouse and resulted in significant reduction in mean weight(11848 mg, P>0.05) and crown-rump length(11.90.23 mm, P>0.05) and the overall size of fetuses compared to control group, whereas there was no significant difference between the groups receiving low dose of Origanum Vulgare extract with control group. In addition, under the effect of the Origanum Vulgare extract the subcutaneous bleeding seemed (20.1, P>0.05) significantly more frequent compared to the control group.
Conclusion: Origanum Vulgare extract did not have any positive effect on fetal development and high dosages led to an increased incidence rate of abortion and fetal malformations in the fetuses of women who received it.

Page 1 from 1     

© 2024 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by : Yektaweb